The COVID-19 dashboards created by Regenstrief Institute and its partners have been instrumental in the decision making of public health and healthcare leaders. 

Regenstrief Research Scientist Angela Rollins, PhD, was a guest editor for a special section in the Psychiatric Rehabilitation Journal. The issue focused on the efforts to understand the wellness of the workforce that provides psychiatric rehabilitation services.

In a presentation at the American Medical Informatics Association’s 2021 Annual Symposium, Paul Dexter, M.D. and Titus Schleyer, DMD, PhD, discussed how computerized clinical decision support will be essential to ensuring the safety and efficiency of collaborative care models.

Regenstrief Institute and Merck & Co., Inc. conducted the first study to qualitatively describe primary care providers’ experience evaluating and treating chronic cough.

Regenstrief Institute data experts are actively working to further the understanding of COVID-19 through real-world data. In the last week, the Regenstrief chief executive officer and a vice president have been lead authors on papers published in the U.S. Centers for Disease Control and Prevention (CDC)’s Morbidity and Mortality Weekly Report (MMWR).

Regenstrief Research Scientist Jennifer Maratt, M.D., M.S., co-authored a commentary in Gastroenterology about the benefits of gene-specific surveillance colonoscopy strategies for Lynch Syndrome, an inherited syndrome that increases risk for colon cancer.

Christopher M. Callahan, M.D., a Regenstrief Institute research scientist, co-authored an editorial in the Journal of the American Geriatrics Society (JAGS), “Improving care for dementia: Re-imagining the advocacy playbook,” that observes dementia care focused at the community, policy, and societal levels urgently requires more attention from researchers and clinicians.